RECENT NEWS

The evolving strategic relationship will drive the use of artificial intelligence (AI)-powered pathology in translational research and clinical trials.

Biocytogen has entered into a global licensing agreement with Merck for the use of Biocytogen’s RenMice platform.

Designed for laboratories performing highly sensitive and precise DNA and RNA analysis in areas such as oncology and infectious diseases, the Digital LightCycler System is a next-generation digital PCR system that helps clinical researchers better understand the nature of a patient’s condition.

The new state-of-the-art facility in Plainville, Massachusetts will be manufacturing materials central to production of gene-based therapeutics.

The new collaboration will create an auto-sampling workflow to reduce errors and accelerate analysis.

The Microbiology Society has announced the finalists of the 2022 Sir Howard Dalton Young Microbiologist of the Year competition.

The global molecular diagnostics market size is expected to reach USD 50.94 Billion in 2030 and register a revenue CAGR of 12.4% over the forecast period, according to the latest report. The rising prevalence of infectious diseases and cancer is anticipated to fuel demand for molecular diagnostic tests.

The two new posts see an in-house microbiology laboratory established to accelerate the company’s product development.

PhoenixSoft’s Data Companion solution has been deployed at Milton Keynes University Hospital (MKUH) NHS Foundation Trust to provide enhanced and real-time access to pathology data to support performance monitoring and rapid response to ad hoc data queries.

Submissions are now open for the 2022 Lab Awards

The Royal College of Pathologists has launched the Pathology Portal, a new educational resource for trainees, practicing pathologists, scientists and those in pathology-linked roles.

Blackpool Teaching Hospitals received a VIP guest of honour early in August, when Dr Michael Osborn, president of The Royal College of Pathologists, officially opened the Trust’s new histopathology laboratory.

New research - published recently in Nature - offers new opportunities to improve diagnostics and targeted therapy for many cancer patients.

The two companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide.

The NHS in Lancashire and South Cumbria is set to pioneer the use of drone technology to deliver medical samples between selected hospital sites thanks to around £1.4m in UK Research and Innovation funding.

Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing the power of advanced microscopy solutions.

Linkam, a market leader in temperature and environmental-controlled microscopy, presented its range of cryo workflow solutions and sample characterisation tools at Microscopy and Microanalysis (M&M) 2022.

Bio-Rad Laboratories has extended its range of StarBright dyes to include StarBright Violet 760, StarBright UltraViolet 575 and StarBright UltraViolet 605 dyes, offering improved brightness with narrow excitation and emission profiles.

‘Point of Care: Innovations’ is a free-to-attend meeting for NHS staff being held in Bristol at The Bristol – Harbourside (Doyle Collection) hotel on 20 September. Click on this item to access the confirmed programme.

Point-of-care testing has found application across the breadth of healthcare, a recent prime example being the role of viscoelastic POC testing in post-partum bleeding management in obstetrics.